Skip to main content

Table 1 Demographic and clinical characteristics

From: Use of the right internal mammary artery and the great saphenous vein for left anterior descending artery revascularization in patients whose left internal mammal artery cannot be used: a study based on transit-time flow measurement

 LIMA-LAD (333)RIMA-LAD (34)SVG-LAD (43)P
Male (n, %)241(72.37)29(85.29)30(69.77)0.110
Age64.27 ± 10.7056.85 ± 11.0170.47 ± 10.250.000
BMI26.64 ± 20.2525.55 ± 2.5123.79 ± 3.090.616
Hypertension (n, %)209(62.76)21(61.76)27(62.79)0.152
Diabetes (n, %)141(42.34)13(38.24)17(39.53)0.036
Hyperlipidemia (n, %)145(43.54)15(44.12)19(44.19)0.455
Previous stroke (n, %)50(15.01)9(26.47)6(13.95)0.158
COPD (n, %)7(2.10)1(2.94)2(4.65)0.451
PVD (n, %)40(12.01)6(17.65)3(8.82)0.723
Previous infarction (n, %)65(19.52)6(17.65)7(16.28)0.730
PCI49(14.71)6(17.65)8(18.60)0.719
Number of anastomosis3.04 ± 0.942.78 ± 0.873.24 ± 1.070.121
NYHA2.30 ± 0.512.33 ± 0.602.28 ± 0.510.911
LVEF (%, ±s)62.87 ± 25.1862.81 ± 9.5061.40 ± 8.780.927
LVEDd (cm, ±s)50.69 ± 7.03450.25 ± 6.20151.43 ± 6.640.741
  1. BMI Body mass index, COPD Chronic obstructive pulmonary disease, PVD peripheral vascular diseases, PCI Percutaneous coronary intervention, NYHA New York Heart Association, LVEF left ventricular ejection fraction, LVEDd Left ventricular end-diastolic dimension, LIMA Left internal mammary artery, SVG Great saphenous vein, RIMA Right internal mammary artery, LAD Left anterior descending artery